Retatrutide

Description

Triple-incretin agonist studied in metabolic research for its combined effect across three receptor targets.

Sequence/composition: Triple GIP/GLP-1/glucagon receptor agonist analog
Purity: 99.1%
Molecular weight: 4730.6 g/mol

For laboratory research use only. Not for human or veterinary use.